425 related articles for article (PubMed ID: 8453642)
21. Molecular cytogenetic alterations in the early stage at human bronchial epithelial cell carcinogenesis.
Dong XY; Lu YJ; Tong T; Wang YJ; Guo SP; Bai JF; Han NJ; Cheng SJ
J Cell Biochem Suppl; 1997; 28-29():74-80. PubMed ID: 9589351
[TBL] [Abstract][Full Text] [Related]
22. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras.
Soejima K; Fang W; Rollins BJ
Oncogene; 2003 Jul; 22(30):4723-33. PubMed ID: 12879017
[TBL] [Abstract][Full Text] [Related]
23. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
24. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
[TBL] [Abstract][Full Text] [Related]
25. Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene.
Cheah MS; Wallace CD; Hoffman RM
J Natl Cancer Inst; 1984 Nov; 73(5):1057-65. PubMed ID: 6092764
[TBL] [Abstract][Full Text] [Related]
26. Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells.
Damiani LA; Yingling CM; Leng S; Romo PE; Nakamura J; Belinsky SA
Cancer Res; 2008 Nov; 68(21):9005-14. PubMed ID: 18974146
[TBL] [Abstract][Full Text] [Related]
27. Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation.
Reddel RR; Ke Y; Kaighn ME; Malan-Shibley L; Lechner JF; Rhim JS; Harris CC
Oncogene Res; 1988; 3(4):401-8. PubMed ID: 3067190
[TBL] [Abstract][Full Text] [Related]
28. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
29. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
Feng G; Xu X; Youssef EM; Lotan R
Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
[TBL] [Abstract][Full Text] [Related]
30. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
De Marzo AM; Marchi VL; Yang ES; Veeraswamy R; Lin X; Nelson WG
Cancer Res; 1999 Aug; 59(16):3855-60. PubMed ID: 10463569
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
32. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
33. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
Schiller JH; Bittner G
Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
[TBL] [Abstract][Full Text] [Related]
34. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
35. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
36. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
37. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas.
Dammann R; Takahashi T; Pfeifer GP
Oncogene; 2001 Jun; 20(27):3563-7. PubMed ID: 11429703
[TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
[TBL] [Abstract][Full Text] [Related]
39. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
40. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
